Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes includingTGFB1andMMP13

6 Jun 2017

Abstract excerpt

// Pauline Hascoet 1 , Franck Chesnel 1 , Florence Jouan 1, ** , Cathy Le Goff 1 , Anne Couturier 1 , Eric Darrigrand 2 , Fabrice Mahe 2 , Nathalie Rioux-Leclercq 3 , Xavier Le Goff 1, * and Yannick Arlot-Bonnemains 1, * 1 CNRS, UMR 6290 IGDR, Université Rennes 1, BIOSIT, Rennes, France 2 IRMAR, Université Rennes 1, Rennes, France 3 CHU Rennes, Service d’Anatomo-Pathologie, Rennes, France * Co-last authors **...

Topics

Join the communities discussing this publication.

Cancer, Hypoxia, and Metabolism
Cancer Research and Treatments
Renal cell carcinoma treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29100286
DOI: 10.18632/oncotarget.18376

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes includingTGFB1andMMP13PMID 29100286Read ↗

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevanceSemantic proximity Read ↗

VHL, the story of a tumour suppressor gene.Semantic proximity Read ↗

Role of the<i>VHL</i>(von Hippel–Lindau) gene in renal cancer: a multifunctional tumour suppressorSemantic proximity Read ↗

Recent advances in etiology and treatment of von Hippel-Lindau Disease (VHLD).Semantic proximity Read ↗

VHL missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic responseSemantic proximity Read ↗

Two sides to every story: the HIF-dependent and HIF-independent functions of pVHLSemantic proximity Read ↗

Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.Semantic proximity Read ↗

The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?Semantic proximity Read ↗

Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression.Semantic proximity Read ↗

[Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer].Semantic proximity Read ↗

Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL <sup>−/−</sup> clear cell renal carcinomaSemantic proximity Read ↗

Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.